Jeffrey E. Russel

Array ( [id] => 993690 [patent_doc_number] => 06916789 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-07-12 [patent_title] => 'Peyer\'s patch and/or M-cell targeting ligands' [patent_app_type] => utility [patent_app_number] => 10/185815 [patent_app_country] => US [patent_app_date] => 2002-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 57 [patent_no_of_words] => 13132 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/916/06916789.pdf [firstpage_image] =>[orig_patent_app_number] => 10185815 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 616450 [patent_doc_number] => 07144862 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-12-05 [patent_title] => 'Orally administered peptides to ameliorate atherosclerosis' [patent_app_type] => utility [patent_app_number] => 10/187215 [patent_app_country] => US [patent_app_date] => 2002-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 37 [patent_no_of_words] => 34318 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/144/07144862.pdf [firstpage_image] =>[orig_patent_app_number] => 10187215 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 535157 [patent_doc_number] => 07173012 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-02-06 [patent_title] => 'Hypoglycaemic peptides and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 10/481662 [patent_app_country] => US [patent_app_date] => 2002-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 7156 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/173/07173012.pdf [firstpage_image] =>[orig_patent_app_number] => 10481662 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6687972 [patent_doc_number] => 20030031697 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-13 [patent_title] => 'Crosslinkable macromers' [patent_app_type] => new [patent_app_number] => 10/176203 [patent_app_country] => US [patent_app_date] => 2002-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12650 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0031/20030031697.pdf [firstpage_image] =>[orig_patent_app_number] => 10176203 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 715826 [patent_doc_number] => 07053053 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-05-30 [patent_title] => 'Humanin-like peptide and use thereof' [patent_app_type] => utility [patent_app_number] => 10/481044 [patent_app_country] => US [patent_app_date] => 2002-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 25716 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/053/07053053.pdf [firstpage_image] =>[orig_patent_app_number] => 10481044 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7206431 [patent_doc_number] => 20040087497 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-06 [patent_title] => 'CD10-activated prodrug compounds' [patent_app_type] => new [patent_app_number] => 10/167627 [patent_app_country] => US [patent_app_date] => 2002-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 38479 [patent_no_of_claims] => 90 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20040087497.pdf [firstpage_image] =>[orig_patent_app_number] => 10167627 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7264930 [patent_doc_number] => 20040242466 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-02 [patent_title] => 'Use of a glycoprotein for the treatment and re-epithelialisation of wounds' [patent_app_type] => new [patent_app_number] => 10/480538 [patent_app_country] => US [patent_app_date] => 2004-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 1061 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0242/20040242466.pdf [firstpage_image] =>[orig_patent_app_number] => 10480538 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 707921 [patent_doc_number] => 07060708 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-06-13 [patent_title] => 'Active agent delivery systems and methods for protecting and administering active agents' [patent_app_type] => utility [patent_app_number] => 10/156527 [patent_app_country] => US [patent_app_date] => 2002-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 45 [patent_no_of_words] => 88029 [patent_no_of_claims] => 77 [patent_no_of_ind_claims] => 28 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/060/07060708.pdf [firstpage_image] =>[orig_patent_app_number] => 10156527 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6328944 [patent_doc_number] => 20020198140 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-26 [patent_title] => 'Pulmonary insulin crystals' [patent_app_type] => new [patent_app_number] => 10/152535 [patent_app_country] => US [patent_app_date] => 2002-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3361 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0198/20020198140.pdf [firstpage_image] =>[orig_patent_app_number] => 10152535 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1022101 [patent_doc_number] => 06888007 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-05-03 [patent_title] => 'Crystalline forms of EtO2C-Ch2-(R)Cgi-Aze-Pab-OH' [patent_app_type] => utility [patent_app_number] => 10/147908 [patent_app_country] => US [patent_app_date] => 2002-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10487 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/888/06888007.pdf [firstpage_image] =>[orig_patent_app_number] => 10147908 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1022101 [patent_doc_number] => 06888007 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-05-03 [patent_title] => 'Crystalline forms of EtO2C-Ch2-(R)Cgi-Aze-Pab-OH' [patent_app_type] => utility [patent_app_number] => 10/147908 [patent_app_country] => US [patent_app_date] => 2002-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10487 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/888/06888007.pdf [firstpage_image] =>[orig_patent_app_number] => 10147908 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7083818 [patent_doc_number] => 20050049198 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-03 [patent_title] => 'Method of modulating the activity of calcium channels in cardiac cells and reagents therefor' [patent_app_type] => utility [patent_app_number] => 10/478112 [patent_app_country] => US [patent_app_date] => 2002-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 15284 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20050049198.pdf [firstpage_image] =>[orig_patent_app_number] => 10478112 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 774191 [patent_doc_number] => 07001991 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-02-21 [patent_title] => 'Targeted delivery of bioaffecting compounds for the treatment of cancer' [patent_app_type] => utility [patent_app_number] => 10/477998 [patent_app_country] => US [patent_app_date] => 2002-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11932 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/001/07001991.pdf [firstpage_image] =>[orig_patent_app_number] => 10477998 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7612650 [patent_doc_number] => 06903185 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-06-07 [patent_title] => 'Poly zinc finger proteins with improved linkers' [patent_app_type] => utility [patent_app_number] => 10/146221 [patent_app_country] => US [patent_app_date] => 2002-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 10 [patent_no_of_words] => 16888 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 148 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/903/06903185.pdf [firstpage_image] =>[orig_patent_app_number] => 10146221 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6701595 [patent_doc_number] => 20030224475 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-04 [patent_title] => ' Lipodepsipeptide antibiotics and methods of preparation' [patent_app_type] => new [patent_app_number] => 10/142303 [patent_app_country] => US [patent_app_date] => 2002-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7469 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20030224475.pdf [firstpage_image] =>[orig_patent_app_number] => 10142303 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1126887 [patent_doc_number] => 06790830 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-09-14 [patent_title] => 'Use of 3-position cyclosporin derivatives for hair growth' [patent_app_type] => B2 [patent_app_number] => 10/141723 [patent_app_country] => US [patent_app_date] => 2002-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 9796 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/790/06790830.pdf [firstpage_image] =>[orig_patent_app_number] => 10141723 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1222838 [patent_doc_number] => 06699467 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-03-02 [patent_title] => 'Compounds and compositions for delivering active agents' [patent_app_type] => B2 [patent_app_number] => 10/142009 [patent_app_country] => US [patent_app_date] => 2002-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10954 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/699/06699467.pdf [firstpage_image] =>[orig_patent_app_number] => 10142009 [rel_patent_id] =>[rel_patent_doc_number] =>)